上海荣泰健康科技股份有限公司关于公司参与股权投资基金的公告

Investment Overview - The company has invested RMB 10 million in Tianjin Dinghui No. 2 Equity Investment Partnership, accounting for 10.3648% of the total subscribed capital of the partnership [2][4] - The investment aims to expand into emerging sectors while ensuring operational capital needs and manageable overall investment risks [4] Approval Process - The investment was approved by the company's management and does not require board or shareholder approval, as it falls within the management's authority [5] Fund Partner Information - Shenzhen Fenghou Wotian Venture Capital Co., Ltd. serves as the general partner and fund manager of the partnership [8] - The company is not a defaulter and has completed the necessary registration with the Asset Management Association of China [12][11] Fund Details - The fund, established on May 8, 2024, has a target size of RMB 3 billion and focuses on private equity investments in sectors such as intelligent manufacturing, new information technology, and semiconductors [14][15] - The fund's investment strategy includes direct or indirect investments in private equity funds and unlisted companies [20] Investment Purpose and Impact - The investment is expected to leverage the expertise and resources of professional institutions to enhance the company's investment capabilities and optimize its industrial layout [28] - The funding source is the company's own capital, ensuring that normal operations and financial conditions remain unaffected [28]